LEP and obesity due to melanocortin 4 receptor deficiency: Because in patients with type 2 diabetes insulin therapy retained the ability to lower blood glucose despite hyperinsulinemia and insulin resistance, many hoped that, despite hyperleptinemia, leptin therapy might be effective in typical obesity and obesity-associated diabetes.